Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
04:30pm, Wednesday, 13'th Mar 2024
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain
Smith & Nephew: Scepticism has been overplayed, says leading investment bank
10:25am, Monday, 11'th Mar 2024
JP Morgan has spotlighted Smith & Nephew PLC (LSE:SN) for its revenue acceleration and margin expansion potential, setting a price target of 1,300p - a 21% premium to the current stock price. Despite
Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript
01:13am, Wednesday, 28'th Feb 2024
Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript
Smith & Nephew profits meet targets, 'robust' growth expected in 2024
03:08am, Tuesday, 27'th Feb 2024
Smith & Nephew PLC (LSE:SN) kept its dividend unchanged and guided to solid growth this year as it reported 2023 results in line with improved guidance from last summer. The hip and knee replacement s
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
04:40pm, Wednesday, 21'st Feb 2024
There are some key robotics stocks for investors to buy in February. This is amid the broader indices such as the Nasdaq making a brief pullback.
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
10:46am, Wednesday, 21'st Feb 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use wit
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* fo
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
08:00am, Monday, 12'th Feb 2024
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REG
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
10:46am, Wednesday, 24'th Jan 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Australia's approach to musculoskeletal injury care and reimbursement demands rethink: Report
04:00pm, Sunday, 14'th Jan 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and
Smith+Nephew closes acquisition of CartiHeal
03:09am, Wednesday, 10'th Jan 2024
Smith & Nephew PLC (LSE:SN) said today that it has closed the acquisition of CartiHeal, an Israel-based developer of sports medicine technology for cartilage regeneration in the knee. The medical
Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward
06:46am, Thursday, 28'th Dec 2023
Smith & Nephew shares are down 3.6% since February, but management has increased top-line growth guidance for fiscal 2022. The Orthopedics business unit is showing strong growth potential, with moment
Smith & Nephew (SNN) New Buyout Expands Sports Medicine Suite
12:47pm, Tuesday, 28'th Nov 2023
Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.
Smith & Nephew acquires cartilage regeneration firm
03:13am, Wednesday, 22'nd Nov 2023
Smith & Nephew PLC (LSE:SN) has announced the acquisition of knee cartilage regeneration technology developer CartiHeal. Under the agreement, the FTSE 100-listed medical equipment manufacturer will p
